Search alternatives:
teer decrease » greater decrease (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
teer decrease » greater decrease (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
38141
Data Sheet 6_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf
Published 2025“…PDE7 inhibition suppressed the PI3K/AKT/mTOR pathway, upregulated the pro-apoptotic protein Bcl-2 Associated X-protein (BAX) in A2780, and increased IL-6 expression in OVCAR3. …”
-
38142
Data Sheet 1_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf
Published 2025“…PDE7 inhibition suppressed the PI3K/AKT/mTOR pathway, upregulated the pro-apoptotic protein Bcl-2 Associated X-protein (BAX) in A2780, and increased IL-6 expression in OVCAR3. …”
-
38143
Data Sheet 3_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf
Published 2025“…PDE7 inhibition suppressed the PI3K/AKT/mTOR pathway, upregulated the pro-apoptotic protein Bcl-2 Associated X-protein (BAX) in A2780, and increased IL-6 expression in OVCAR3. …”
-
38144
Data Sheet 8_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf
Published 2025“…PDE7 inhibition suppressed the PI3K/AKT/mTOR pathway, upregulated the pro-apoptotic protein Bcl-2 Associated X-protein (BAX) in A2780, and increased IL-6 expression in OVCAR3. …”
-
38145
Data Sheet 4_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf
Published 2025“…PDE7 inhibition suppressed the PI3K/AKT/mTOR pathway, upregulated the pro-apoptotic protein Bcl-2 Associated X-protein (BAX) in A2780, and increased IL-6 expression in OVCAR3. …”
-
38146
Data Sheet 5_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf
Published 2025“…PDE7 inhibition suppressed the PI3K/AKT/mTOR pathway, upregulated the pro-apoptotic protein Bcl-2 Associated X-protein (BAX) in A2780, and increased IL-6 expression in OVCAR3. …”
-
38147
-
38148
-
38149
Metformin induces significant reduction of body weight, total cholesterol and LDL levels in the elderly – A meta-analysis
Published 2018“…Our results also suggest that metformin treatment may reduce the risk of major coronary events (-4-5%) and all-cause mortality (-2%) in elderly diabetic populations.…”
-
38150
Comparative Analysis of the Lambda-Interferons IL-28A and IL-29 regarding Their Transcriptome and Their Antiviral Properties against Hepatitis C Virus
Published 2010“…All hepatic cell lines investigated as well as primary hepatocytes expressed both IFN-λ receptor subunits IL-10R2 and IFN-λR1. Both, IL-28A and IL-29 activated STAT1 signaling. …”
-
38151
-
38152
-
38153
Bodyweight of mice in acute toxicity test.
Published 2024“…Ethanolic extracts of the CTLL and PSCD formulations demonstrated a significant dose-dependent decrease in parasitemia in mice. …”
-
38154
DataSheet_1_Soshiho-Tang, a Traditional Herbal Medicine, Alleviates Atopic Dermatitis Symptoms via Regulation of Inflammatory Mediators.docx
Published 2019“…SST and dexamethasone were administered orally for 14 day. As a result, SST treatment increased the expression of heme oxygenase-1 (HO-1), an anti-oxidative factor, and the nuclear translocation of NF-E2 p45-related factor 2 (Nrf2). …”
-
38155
-
38156
-
38157
Table_2_Short-Term Changes in Mental, Physical, and Social Factors After Metabolic Bariatric Surgery in Adolescents: A Nationwide Prospective Cohort Study.docx
Published 2022“…</p>Methods<p>We followed 97 adolescents (64% females, aged 17 ± 0.9 years, BMI 46.1 ± 5.9 kg/m<sup>2</sup>) before and 9 months following MBS in a multi-center, prospective cohort study. …”
-
38158
Supplementary Material for: An early phase 2 double-blind, placebo-controlled study of E6011, a novel anti-fractalkine antibody, in patients with Crohn’s disease
Published 2025“…Methods: In this early phase 2, double-blind, placebo-controlled study, we examined the efficacy and safety of E6011 in patients with moderate to severe active CD in a 12-week, double-blind period and the long-term efficacy and safety of E6011 in a subsequent open-label period for a maximum of 52 weeks. …”
-
38159
SCS Design 2.
Published 2014“…<p>(a) Target structure. (b) MFE structure of the SCS Design 2 sequence from <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0110986#pone-0110986-t001" target="_blank">Table 1</a>. …”
-
38160
OPJ: Origin data for Fig 4b.
Published 2024“…Thermal and dynamic flow patterns are analyzed for a variety of parameters: Rayleigh numbers from 10<sup>2</sup> to 10<sup>6</sup>, PV panel tilt angle from 15° to 90°, and channel aspect ratios from 1/20 to 1/5. …”